0000000000115029

AUTHOR

C. Quiñones‐torrelo

showing 9 related works from this author

Opioid analgetics retention–pharmacologic activity models using biopartitioning micellar chromatography

2002

Opioids are drugs used in medicine for pain control. In this paper, retention-pharmacokinetics and retention-pharmacodynamics relationships of opioids are proposed and statistically validated. These models are based on the compound retention in the biopartitioning micellar chromatography system (BMC), a new methodology which has successfully been used to develop QRAR models for many other families of compounds. The obtained results are compared to the traditional QSAR models using lipophilicity data. The adequacy of QRAR models is due to the fact that the characteristics of the compounds such as the hydrophobicity, electronic charge and steric effects determine both their retention in BMC a…

Quantitative structure–activity relationshipChromatographyChemistryClinical BiochemistryAnalgesicCell BiologyGeneral MedicinePharmacologyBiochemistryAnalytical ChemistryAnalgesics OpioidStructure-Activity RelationshipModels ChemicalOpioidPain controlPharmacokineticsLipophilicitymedicineOpioid analgesicsChromatography Micellar Electrokinetic Capillarymedicine.drugJournal of Chromatography B
researchProduct

Efficiency of antidepressant drugs as monoamine reuptake inhibitors: analysis of the hydrophobicity influence using biopartitioning micellar chromato…

2004

The reuptake blockade of biogenic amines by antidepressants is related not only to their therapeutics effects, but also to their side effects and potential drug-drug interactions. As an alternative to classical quantitative structure-activity relationships studies, in this work we propose different quantitative retention-activity relationships (QRAR) models that are able to describe the monoamine reuptake inhibition by antidepressants. The retention of compounds is measured using a biopartitioning micellar chromatography (BMC) system that can simulate the same hydrophobic, electronic and steric molecular interactions as those that condition drug activity. Since all the compounds considered …

Clinical BiochemistryPharmacologyBiochemistrySensitivity and SpecificityAnalytical ChemistryReuptakeStructure-Activity RelationshipDrug DiscoveryBiogenic MonoaminesNeurotransmitter Uptake InhibitorsMolecular BiologyMicellesPharmacologyMolecular interactionsChromatographyChemistryGeneral MedicineAntidepressive AgentsMonoamine neurotransmitterDrug activityAntidepressantSpectrophotometry UltravioletMonoamine reuptake inhibitorPharmacophoreReuptake inhibitorChromatography LiquidBiomedical chromatography : BMC
researchProduct

Determination of amobarbital and secobarbital in plasma samples using micellar liquid chromatography

2000

A new liquid chromatographic procedure for the determination of amobarbital and secobarbital in plasma samples is proposed. The method uses a Spherisorb octadecylsilane ODS-2 C18 analytical column, a guard column of similar characteristics and 0.04 M CTAB solution buffered at pH 7.5 containing 3% 1-propanol as micellar mobile phase. The UV detection was carried out at 250 nm. Butabarbital was used as internal standard. Plasma samples preparation only required adequate dilution with the mobile phase before injection into the chromatographic system. The limits of detection were 0.2 and 0.4 mg/L for amobarbital and secobarbital, respectively. The proposed method allows the determination of amo…

PharmacologyDetection limitChromatographyPlasma samplesChemistryButabarbitalAmobarbitalClinical BiochemistryAnalytical chemistryGeneral MedicineSecobarbitalBiochemistryAnalytical ChemistryDilutionMicellar liquid chromatographyDrug DiscoverymedicineUv detectionMolecular Biologymedicine.drugBiomedical Chromatography
researchProduct

Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography.

1999

The distribution of tricyclic antidepressants from plasma to brain, where these drugs exert their main clinical action, and other organs is related to transport events across the cell membranes of the different tissues. It could be expected that all the molecular features that condition the transport processes (mainly hydrophobicity and molar total charge) also control the pharmacokinetic and biochemical behavior. Micellar liquid chromatography (MLC) has been proposed to emulate in vitro the partitioning process in the biomembranes. The use of micellar solutions of Brij35 as mobile phases in reversed-phase liquid chromatography has proven to be valid to predict the biological activities of …

SerotoninAntidepressive Agents TricyclicModels BiologicalMicellar electrokinetic chromatographyNorepinephrineStructure-Activity RelationshipPharmacokineticsReceptors Adrenergic alpha-1Drug DiscoveryDistribution (pharmacology)AnimalsEnzyme InhibitorsAdrenergic alpha-AntagonistsMicelleschemistry.chemical_classificationChromatographyChemistryCapacity factorRatsMembraneMicellar liquid chromatographyMicellar solutionsAdenylyl Cyclase InhibitorsHistamine H1 AntagonistsMolecular MedicineSelective Serotonin Reuptake InhibitorsTricyclicChromatography LiquidJournal of medicinal chemistry
researchProduct

A micellar liquid chromatographic method for quality control of pharmaceutical preparations containing tricyclic antidepressants

2002

Micellar liquid chromatography methods for quality control of pharmaceutical preparations (capsules, pills, tablets, injections) containing the tricyclic antidepressants amineptine, amitriptiline, clomipramine, doxepin, imipramine, melitracen and nortriptyline alone or together with other CNS drugs like diazepam, medazepam and perphenazine are described. The methods using micellar solutions of cetyltrimethylammonium bromide as mobile phases and UV detection are rapid and reproducible. Due to the versatility of interactions in micellar liquid chromatography, it is possible determine highly hydrophobic compounds such as TCAs in a short time using mobile phases containing low organic solvent c…

chemistry.chemical_classificationChromatographyOrganic ChemistryClinical BiochemistryMelitracenDoxepinBiochemistryMicellar electrokinetic chromatographyDosage formAnalytical ChemistryMedazepamchemistryMicellar liquid chromatographyMicellar solutionsmedicineTricyclicmedicine.drugChromatographia
researchProduct

QRAR models for central nervous system drugs using biopartitioning micellar chromatography.

2002

The capability of biopartitioning Micellar Chromatography, BMC, to describe and estimate pharmacokinetic and pharmacodynamic parameters of central nervous system drugs is reviewed in this article. BMC is a mode of micellar liquid chromatography, MLC, that uses micellar mobile phases of Brij35 (polyoxyethilene(23) lauryl ether) prepared in physiological conditions (pH, ionic strength). The retention of a drug in this system depends on its hydrophobic, electronic and steric properties, which also determine its biological activity. The results of BMC studies suggest that this in vitro approach is an attractive useful tool to be implemented into the lead optimization step of drug development sc…

PharmacologyDrugChromatographyChemistrymedia_common.quotation_subjecttechnology industry and agricultureQuantitative Structure-Activity Relationshipmacromolecular substancesGeneral Medicinemusculoskeletal systemModels BiologicalPharmacokineticsDrug developmentIonic strengthMicellar liquid chromatographyDrug DiscoveryAnimalsHumansmedia_commonCentral Nervous System AgentsChromatography Micellar Electrokinetic CapillaryMini reviews in medicinal chemistry
researchProduct

Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography

2001

Abstract Antihistamines are drugs which act by competitive inhibition of the H1 or H2 histamine receptors. Little has been known about their clinical pharmacokinetics and biological responses until the last few years. In this paper, we propose quantitative retention–activity relationship, QRAR, models based on the retention data of antihistamines in a biopartitioning micellar chromatography (BMC) system using a Brij35 mobile phase for describing pharmacokinetic parameters such as half-life and volume of distribution, or the pharmacodynamic parameters, therapeutic plasma levels, lethal doses and drug-receptor dissociation constant. The predictive ability of these models is statistically vali…

Volume of distributionQuantitative structure–activity relationshipChromatographyChemistrymedicine.medical_treatmentQuantitative Structure-Activity RelationshipGeneral ChemistryHigh-performance liquid chromatographyDissociation constantPharmacokineticsPharmacodynamicsLipophilicityHistamine H1 AntagonistsmedicineSpectrophotometry UltravioletAntihistamineChromatography LiquidJournal of Chromatography B: Biomedical Sciences and Applications
researchProduct

An LD50model for predicting psychotropic drug toxicity using biopartitioning micellar chromatography

2001

The LD50 determination is the main way to measure the acute toxicity of all types of substances. At the present time, however, there is increasing opposition to the use of living animals in research and testing activities from animal rights groups as well as some scientists. Nevertheless, the need to have a tool for estimating the potential toxicity of new compounds for human consumption has encouraged the development of alternative methods. Under adequate conditions, the partitioning in micellar liquid chromatography can describe the drug biopartitioning. We have named this chromatographic system biopartitioning micellar chromatography (BMC). In this paper, an LD50 QRAR model developed for…

PharmacologyDrugAlternative methodsChromatographyChemistrymedia_common.quotation_subjectClinical BiochemistryGeneral MedicinePharmacologyBiochemistryAcute toxicityAnalytical ChemistryPsychotropic drugMicellar liquid chromatographyDrug DiscoveryToxicityMolecular Biologymedia_commonPotential toxicityBiomedical Chromatography
researchProduct

Role of hydrophobicity on the monoamine receptor binding affinities of central nervous system drugs: a quantitative retention-activity relationships …

2004

Abstract Biological action and activity reflect an aspect of the fundamental physicochemical properties of the bioactive compounds. As an alternative to classical QSAR studies, in this work different quantitative retention–activity relationships (QRAR) models are proposed, which are able to describe the role of hydrophobicity on the binding affinity to different brain monoamine receptors (H 1 -histamine, α 1 -noradrenergic and 5-HT 2 -serotonergic) of different families of psychotherapeutic drugs. The retention of compounds is measured in a biopartitioning micellar chromatography (BMC) system using Brij-35 mobile phases. The adequacy of the QRAR models developed is due to the fact that both…

Steric effectsQuantitative structure–activity relationshipStereochemistryClinical BiochemistryQuantitative Structure-Activity RelationshipSerotonergicBiochemistryAnalytical ChemistryReceptors Biogenic AmineReceptors Adrenergic alpha-1AnimalsReceptors Histamine H1ReceptorMicellesChromatographyChromatographyMolecular StructureChemistryCell MembraneBrainCell BiologyGeneral MedicineAffinitiesMonoamine neurotransmitterSerotonin 5-HT2 Receptor AntagonistsPharmacophoreReceptors Serotonin 5-HT2Quantitative analysis (chemistry)Central Nervous System AgentsJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
researchProduct